In the Netherlands, Mevaldi B.V. has successfully closed a funding round with High-Tech Gründerfonds and ICIG Ventures, the investment arm of International Chemical Investors Group.
Founded in 2020, Mevaldi is pioneering a bio-thermocatalytic process to produce 3-methyl-1,5-pentanediol—a versatile chemical used in coatings, adhesives, and elastomers. The investment, which includes both equity and a working capital facility, will support Mevaldi’s transition from pilot to demonstration-scale production.
Currently, all manufacturing is carried out within Europe, utilizing ICIG’s existing plant infrastructure.
“We’re thrilled to welcome HTGF and ICIG Ventures as strategic partners,” said Mevaldi CEO Roger Ottenheym. “Their strong track record in scaling technologies and commitment to sustainability make them ideal collaborators for our next phase of growth.”